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The 2013 Nobel Prize in Physiology or Medicine has been awarded to James Rothman, Randy
Schekman, and Thomas Su¨dhof ‘‘for their discoveries of machinery regulating vesicle traffic,
a major transport system in our cells’’. I present a personal view of the membrane trafficking field,
highlighting the contributions of these three Nobel laureates in a historical context.Our story begins in 1974, when I was a UC
Berkeley undergraduate. Jim Rothman
was studying the properties of phospho-
lipids in membrane bilayers with Eugene
Kennedy at Harvard, and Randy Schek-
man, who had just completed a PhD at
Stanford University for work with Arthur
Kornberg on DNA replication, joined the
lab of Jonathan Singer at UC San Diego
to study protein mobility in cell mem-
branes. Singer and Garth Nicholson had
just published a fluid mosaic model for
the organization of lipids in bilayers. It is
hard to imagine that the simple structure
of cellular membranes was still being
debated at that time. During the same
year, George Palade, with Albert Claude
and Christian de Duve, was awarded the
Nobel Prize in Physiology or Medicine
for his groundbreaking electron micro-
scopy studies of protein secretion from
the exocrine pancreas. It was Palade
who established the concept that proteins
synthesized on membrane-bound ribo-
somes are transported, vectorially, into
the lumen of the endoplasmic reticulum
(ER) before transport to the Golgi com-
plex and secretory storage granules for
subsequent export from cells. In 1974,
the concept of the secretory pathway
being used to create the limiting mem-
brane of cells was still only a supposition.
And although Palade surmised that the
abundant, small vesicles that surrounded
the Golgi complex in his electron micro-
graphs participated in transport between
membrane compartments, this was not
yet fully established (Palade, 1975).
Gu¨nter Blobel solved the first step of
the Palade pathway, and he received the
Nobel Prize in Medicine or Physiology in
1999 ‘‘for the discovery that proteins
have intrinsic signals that govern theirtransport and localization in the cell.’’
But how proteins were transported from
their site of synthesis to the cell surface
was not yet known.
In 1976, Schekman began his lab as
an Assistant Professor at the University
of California at Berkeley, and chose to
study protein secretion in baker’s yeast.
I first met Schekman then, as a biochem-
istry major, working in a lab on the same
floor. Lee Hartwell, then at the University
of Washington, had just reported his use
of yeast genetics to identify the genes
responsible for driving the cell-division
cycle, which yielded Hartwell a Nobel
Prize in Medicine or Physiology in 2001
with Paul Nurse and Tim Hunt. Today,
yeast is a very popular experimental
system, but in 1976, it was not at all clear
that yeast would contain a secretory
pathway or whether secretion in yeast
would in any way, reflect pathways used
by human cells. Schekman and a grad-
uate student, Peter Novick, took a very
bold step and established a set of
conditional mutant yeast strains that
were temperature sensitive for cell-sur-
face growth (Novick and Schekman
1979). These strains were termed, sec
mutants for secretion mutants.
Subsequent work by Schekman and
colleagues identified 23 complementation
groups and electron microscopy con-
firmed that cells bearing sec mutations
accumulated vesicles or other organelles
when grown at the nonpermissive tem-
perature (Figure 1A) (Novick et al., 1980).
Later, inspired by his earlier training with
Arthur Kornberg and the success of
James Rothman and colleagues in recon-
stituting membrane traffic events (see
below), Schekman and coworkers estab-
lished a cell-free system to study proteinCell 155, Dtransport from the endoplasmic reticulum
(ER) to the Golgi (Baker et al., 1988) and in
1990, published a careful double-mutant
electron microscopy study that ordered
all the SEC gene products. Because
vesicles accumulated as intermediates
upon loss of the function of certain SEC
gene products, this study was the first
to demonstrate the role of discrete
transport vesicles as true intermediates
in the process by which proteins move
through the secretory pathway in yeast.
Schekman and his colleagues spent
the next several years cloning the genes
encoding SEC proteins and examining
their functions in driving vesicle transport
from the ER to the Golgi complex. His
work led to the discovery of the COP-II
coat that drives this process (Figure 1C)
(Barlowe et al., 1994). The fundamental
importance of this discovery is best
appreciated when one considers that
more than one-third of the human
genome encodes proteins that must
traverse the secretory pathway, and
COP-II-coated vesicles carry them from
the ER to the Golgi. Nothing was known
about the molecular basis for this process
before Schekman’s pioneering work. And
the Schekman lab environment was so
encouraging of ‘‘collaborations’’ that a
number of lab member pairs got married
during this period.
Two years after Schekman arrived at
UC Berkeley, James Rothman started
his lab at Stanford University. Also
inspired by Arthur Kornberg and his
colleagues in the Department of
Biochemistry, Rothman took a biochem-
ical approach and set up a cell-free
system to study ER-to-Golgi transport
using mammalian cell components (Fries
and Rothman 1980). Subsequent workecember 5, 2013 ª2013 Elsevier Inc. 1203
Figure 1. Milestones from the Path to the Prize
(A) Accumulation of secretory vesicles in mutant cells at the permissive (top) or nonpermissive temperature (bottom) (from Novick et al., 1980).
(B) Purified COP-I vesicles that mediate intra-Golgi transport and transport from the Golgi to the ER (Malhotra, V., et al. [1989]. Cell 58, 329–336).
(C) Purified COP-II vesicles that carry proteins from the ER to the Golgi (Barlowe et al., 1994).
(D) A synapse from embryonic cultured hippocampal neurons showing normal synaptic vesicle morphology (Janz, R., et al. [1999]. Neuron 24, 1003–1016).
A fraction of vesicles are docked at the active zone, poised for rapid release in a highly calcium dependent manner.revealed that the reconstituted reaction
represented transfer of a glycoprotein
from one Golgi stack to another. Three
papers spearheaded by Bill Balch and
Bill Dunphy in the Rothman laboratory in
the mid-1980s reported a more stream-
lined assay and showed that the donor
and acceptor membranes for the reaction
represented distinct stacks of Golgi
membranes (cf. Balch et al., 1984). I
worked in Rothman’s lab as a postdoc in
1984 and 1985 when this work had just
been published; I followed the subse-
quent developments closely as a new
faculty member in a nearby lab.
Many cell biologists were very skeptical
of the in vitro findings that Rothman
reported in the mid-1980s. The work
represented the first reconstitution of a
membrane trafficking step in the test
tube, and up to this time, microscopists
rather than biochemists had dominated
the field. Complicating matters was the
fact that Rothman is a forceful visionary
who was so eager to move the field for-
ward that a few mistakes were made
along the way. For example, at one point,
Rothman believed that clathrin-coated
vesicles carry proteins from the ER to
the Golgi. A few missteps did not deter
Rothman from later finding the answers1204 Cell 155, December 5, 2013 ª2013 Elsehe was seeking. We now know that
so-called COP-II-coated vesicles, discov-
ered by Schekman, are responsible for
this process, in all eukaryotes, large and
small. And Vivek Malhotra and Rothman
were the first to show that COP-I vesicles
mediate protein transport within the Golgi
stack (Figure 1B). These independent
discoveries in the Schekman and Roth-
man laboratories would not have been
possible without the help of the electron
microscopist, Lelio Orci.
A very important breakthrough came
when Rothman and coworkers purified
the first enzyme that was needed for
the in vitro transport reaction they had
reconstituted (Block et al., 1988). They
identified a protein that had an N-ethyl-
maleimide (NEM)-sensitive, active site
thiol group that was needed for the
in vitro transport reaction. The protein
was named, NSF for NEM-sensitive fac-
tor. While today this sounds straightfor-
ward, imagine that you have an assay for
a process that requires addition of crude
cytosolic proteins, and ten proteins are
provided by this crude cytosol. If you
want to purify those proteins, you might
use chromatography to separate cytosol
according to charge or size. But as soon
as you separate the cytosol into differentvier Inc.fractions and test their activity, it is likely
that none of the fractions will be active
because the other nine essential compo-
nents are no longer there. Every assay
needed to be carried out using biochem-
ical complementation—and lucky for
Rothman, only one component was
sensitive to NEM. This meant that assays
of different fractions could be carried out
in the presence of a small amount of
NEM-treated cytosol to reveal the desired
activity.
The next breakthrough came when
Rothman and colleagues cloned the
gene encoding the NSF protein and found
it was homologous to the SEC18 gene
product discovered by Schekman and
coworkers to be essential for membrane
transport in yeast (Wilson et al., 1989)
and had been cloned and sequenced
earlier by Scott Emr, a former Schekman
postdoc. This discovery demonstrated
that the process that Rothman had recon-
stituted reflected a physiological and
highly conserved process. Now, two
entirely independent lines of investigation
could proceed synergistically to reveal
the molecular events mediating these
fundamental cellular processes. Doug
Clary in Rothman’s group next identified
a set of soluble proteins that are needed
for NSF binding to membranes (soluble
NSF adaptor proteins or ‘‘SNAPS’’) (Clary
et al., 1990). These turned out to be
homologous to the yeast SEC17 gene
product. This finding was, again, very
important—Schekman’s work provided
the genetic proof for the significance of
the Rothman biochemistry.
Discovery of SNARE Proteins—the
Fusion Machinery
In October 1992, Giampietro Schiavo and
Cesare Montecucco published a paper
showing that the target of tetanus and
botulinum-B proteolytic neurotoxins was
the synaptic vesicle protein, VAMP1/
synaptobrevin. This demonstrated that
VAMP1, a protein first discovered by
Richard Scheller from electric fish and
later found in mammals as synaptobrevin
by Tom Su¨dhof and Reinhard Jahn, was
essential for synaptic vesicle release.
But this finding did not provide a mecha-
nism by which VAMP1 participates in
synaptic vesicle release. In early 1993,
So¨llner and Rothman (So¨llner et al.,
1993a) published a landmark paper that
provided the key clue as to how transport
vesicles could fuse with specific targets.
Rothman and coworkers had shown
that membrane transport in vitro required
the membrane association of NSF, medi-
ated by the soluble NSF adaptor proteins
or SNAPs. They knew that NSF was an
ATPase and that ATP hydrolysis released
NSF from membranes in vitro. They thus
searched for the membrane associated
‘‘receptor’’ for the SNAPs and NSF,
reasoning that the receptor would be a
membrane component needed for vesicle
fusion. Rothman’s colleagues incubated
immobilized, recombinant NSF with puri-
fied SNAP protein, together with a deter-
gent extract of rat brain membranes
as a source of the NSF/SNAP receptor.
They first incubated the mixture under
conditions in which ATP could not be
hydrolyzed (ATPgS), and then added
Mg-ATP and collected the ATP-released
material. The remarkable finding was
that a discrete set of proteins eluted
from the column—and somewere already
known to be synaptic vesicle constituents
(VAMP1/synaptobrevin), a component
of the presynaptic plasma membrane,
syntaxin (cloned earlier by Akagawa
as well as Richard Scheller), and a
synaptosome-associated protein, SNAP-25 (discovered by Michael Wilson and
not yet known to be needed for exocy-
tosis). Rothman’s use of rat brains as a
source of abundant membranes was a
lucky choice because rat brain synaptic
components were already well studied
by neuroscientists.
Mark Bennett and Scheller had just
shown that the presynaptic plasma mem-
brane protein, syntaxin binds to another
synaptic vesicle protein, synaptotagmin.
Rothman proposed that NSF helped drive
membrane fusion by acting on a complex
of a vesicle protein (in this case VAMP1)
bound to a target protein, syntaxin. The
So¨llner/Rothman experiment represented
the first functional possibility that these
proteins represented the players actually
driving membrane fusion.
In collaboration with Richard Scheller,
Rothman went on to show that the
Soluble NSF adaptor protein receptors
(VAMP, SNAP25 and syntaxin, named
SNAREs) formed a tight complex that
could be dissociated by NSF protein
(So¨llner et al., 1993b). More information,
including contributions from Bill Wickner,
made it seem more likely that NSF’s role
would be to help recycle SNARE proteins
after a fusion reaction. Rothman was
later able to fully reconstitute a fusion
reaction using only purified SNARE pro-
teins (Weber et al., 1998). The subsequent
three-dimensional structure of a SNARE
complex by Axel Brunger and colleagues
in 1998 cemented the notion that forma-
tion of complex between SNARE proteins
on vesicles and on target membranes
was the very likely mechanism by which
membranes fuse. And several of the yeast
proteins needed for secretion were ho-
mologous to the synaptic vesicle SNARE
proteins, providing a homologous set of
proteins to drive all of the specific mem-
brane fusion events that take place in
the cell cytoplasm.
Calcium Regulation in Dallas
Tom Su¨dhof enters this story somewhat
later, and although he is now my Stanford
colleague, most of the work for which
he is honored was carried out before he
arrived in California. Su¨dhof received the
Dr. Med. degree in 1982, studying the
secretory granules of neuroendocrine
cells and a calcium-binding protein from
electric rays, with Victor Whittaker at the
Max-Planck-Institut fu¨r BiophysikalischeCell 155, DChemie in Go¨ttingen, Germany. He then
worked as a postdoctoral fellow with
Mike Brown and Joe Goldstein at the
University of Texas Southwestern Medi-
cal Center studying the LDL receptor
gene—its cloning and regulation. In 1986
he joined the faculty at the University
of Texas Southwestern Medical Center
and returned to his neuroscience roots,
applying newly learned molecular biology
skills to this important field. With Reinhard
Jahn, Su¨dhof cloned a number of synap-
tic vesicle proteins, and he showed that
Rab3 GTPase was a synaptic vesicle
protein; he also discovered the protein,
complexin, which is a critical regulator of
SNARE pairing, and the protein Munc18
that is an essential component of the
synaptic vesicle fusion protein complex.
Munc18 is an SM (Sec1/Munc18-like)
protein, a family of proteins that control
the availability and ability of SNARE
proteins to form fusogenic complexes
for all membrane traffic events (Su¨dhof
and Rothman, 2009).
Since the discovery of synaptotagmin
in 1991, a major focus of Su¨dhof’s work
has focused on understanding how this
protein provides calcium regulation to
the process of synaptic vesicle release.
Synaptotagmin contains two protein
kinase C-like C2 domains that bind Ca
2+.
Su¨dhof showed that synaptotagmin
binds to both phospholipids and SNARE
complexes in a Ca2+-regulated manner.
Although synaptotagmin is not abso-
lutely required for synaptic vesicle exocy-
tosis, Su¨dhof and coworkers showed that
synaptotagmin is required for rapid and
coordinated synaptic vesicle release. In
very elegant experiments, he went on to
prove that synaptotagmin functions as
the key calcium sensor by showing that
mice expressing mutant synaptotagmin
proteins with altered calcium affinity
displayed altered calcium sensitivity in
neurotransmitter release (Ferna´ndez-
Chaco´n et al., 2001; Su¨dhof and Roth-
man, 2009). It is the ability of the process
to respond to calcium that enables neu-
rons to secrete neurotransmitter rapidly
and precisely (Figure 1D).
Over several decades, Schekman and
Rothman provided the first identification
of the molecular machinery needed for
transport of proteins through the secre-
tory pathway, a process they showed is
conserved from yeast to humans. Theyecember 5, 2013 ª2013 Elsevier Inc. 1205
each chose a risky path and embraced
a research question of fundamental
importance where they could contribute
essential molecular detail using a combi-
nation of genetics and biochemistry.
Working in parallel, they demonstrated
the importance of transport vesicle inter-
mediates in the secretory pathway and
the mechanisms by which such vesicles
form from the ER (Schekman) and Golgi
(Rothman). Their work revealed the roles
of so-called SNARE proteins in vesicle
fusion with target membranes for all
compartments of the secretory and
endocytic pathways. As for the molecular
basis of synaptic vesicle release, Tom
Su¨dhof made pivotal contributions, along
with others with whom he has previously
been honored. Su¨dhof and Richard
Scheller were corecipients of the 2013
Lasker Award and they also shared the
2010 Kavli Award for Neuroscience with
Rothman. These men were the first to
clone and characterize the proteins
present in purified synaptic vesicles,
obtained and characterized by several
labs, including Reg Kelly’s at UCSF, with
whom I worked as a PhD student.
No single award can recognize all
the individuals who contributed in very1206 Cell 155, December 5, 2013 ª2013 Elseimportant ways to the discoveries sum-
marized here. But I believe that I speak
for the entire field of membrane trafficking
when I say that this award was well
deserved. This month, Jim, Randy, and
Tom have reminded all of us of the impor-
tance of membranes and membrane
trafficking in all of medicine and physi-
ology. And just as Palade left us with
many unanswered questions, there is
still much to be discovered about how
proteins move through the secretory
pathway, how the pathway is established,
and how the pathway is regulated in
health and disease. Congratulations to
these pioneers!
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